Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Omuro

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 30, 2001
[Paclitaxel]Y Omuro, T Sasaki
The Journal of Antibiotics|December 1, 1980
Antibiotic no. 6016, a polyether antibioticY Kusakabe, S Mitsuoka, Y Omuro, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2000
[Standard chemotherapy for gastrointestinal malignancies based on evidence]T Sasaki, Y Maeda, T Kobayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 31, 2000
[New combination therapies for gastrointestinal cancer]T Sasaki, Y Maeda, T Kobayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 1999
[Progress in the treatment of colorectal cancer]T Sasaki, Y Maeda, T Kobayashi, et al.
Japanese Journal of Clinical Oncology|September 8, 1998
Clinical characteristics of patients with metastatic breast cancer with complete remission following systemic treatmentN Yamamoto, N Katsumata, T Watanabe, et al.
Bone Marrow Transplantation|May 16, 2003
Regression of an unresectable pancreatic tumor following nonmyeloablative allogeneic peripheral-blood stem-cell transplantationY Omuro, G Matsumoto, T Sasaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Construction and validation of a practical prognostic index for patients with metastatic breast cancerN Yamamoto, T Watanabe, N Katsumata, et al.
Bone Marrow Transplantation|April 9, 2008
Allo-SCT using reduced-intensity conditioning against advanced pancreatic cancer: a Japanese surveyY Kanda, Y Omuro, E Baba, et al.
British Journal of Cancer|December 22, 1999
Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancerY Tokuda, T Watanabe, Y Omuro, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Gan to Kagaku Ryoho. Cancer & Chemotherapy|October 30, 2001
[Paclitaxel]Y Omuro, T Sasaki
The Journal of Antibiotics|December 1, 1980
Antibiotic no. 6016, a polyether antibioticY Kusakabe, S Mitsuoka, Y Omuro, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2000
[Standard chemotherapy for gastrointestinal malignancies based on evidence]T Sasaki, Y Maeda, T Kobayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 31, 2000
[New combination therapies for gastrointestinal cancer]T Sasaki, Y Maeda, T Kobayashi, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 20, 1999
[Progress in the treatment of colorectal cancer]T Sasaki, Y Maeda, T Kobayashi, et al.
Japanese Journal of Clinical Oncology|September 8, 1998
Clinical characteristics of patients with metastatic breast cancer with complete remission following systemic treatmentN Yamamoto, N Katsumata, T Watanabe, et al.
Bone Marrow Transplantation|May 16, 2003
Regression of an unresectable pancreatic tumor following nonmyeloablative allogeneic peripheral-blood stem-cell transplantationY Omuro, G Matsumoto, T Sasaki, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 1998
Construction and validation of a practical prognostic index for patients with metastatic breast cancerN Yamamoto, T Watanabe, N Katsumata, et al.
Bone Marrow Transplantation|April 9, 2008
Allo-SCT using reduced-intensity conditioning against advanced pancreatic cancer: a Japanese surveyY Kanda, Y Omuro, E Baba, et al.
British Journal of Cancer|December 22, 1999
Dose escalation and pharmacokinetic study of a humanized anti-HER2 monoclonal antibody in patients with HER2/neu-overexpressing metastatic breast cancerY Tokuda, T Watanabe, Y Omuro, et al.
Pageof 2